You searched for "Stone"

1191 results found

In conversation with James Green

We were delighted to catch up with James Green, Consultant Urological Surgeon and new President of the Royal Society of Medicine Section of Urology. Can you tell us a little bit about what led you into the field of urology...

LUTS update

Case study A 70-year-old, generally fit and well male attends your outpatient clinic. He has experienced a gradual deterioration in his voiding over the last few months. Specifically, he reports hesitancy, poor flow and nocturia. He denies visible haematuria. His...

Workshop news update from the upcoming BAUN Conference at the ACC in Liverpool on 4 - 5 November

The British Association of Urological Nurses (BAUN) Conference 2024 takes place from 4-5 November at the ACC in Liverpool. In addition, popular pre-conference workshops are taking place on Sunday 3 November.

SIU (Société Internationale d'Urologie) 2025 Trainee Scholarship: An essential part of the SIU mission

SIU Congresses are the perfect opportunity to expand your knowledge and learn from world-renowned experts. To facilitate the education and training of urologists, SIU offers a merit-based scholarship for select residents / fellows from countries the World Bank classifies as...

BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis

BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...

Action Bladder Cancer UK urges health professionals to help raise awareness during Bladder Cancer Awareness Month in May

Action Bladder Cancer UK is calling on health professionals – including specialist urology and cancer nurses, urologists, oncology and radiology health professionals and others, to support Bladder Cancer Awareness Month by helping to raise awareness of the symptoms of bladder...

Focal therapy for prostate cancer – ready for prime time?

The current therapeutic ratio for radical therapy in many men with localised prostate cancer is not ideal. For a significant side-effect profile, there seems to be a small survival benefit over a 10-15 year period. A strategy that might balance...

Outcomes of renal cancer surgery on renal function and mortality on those with and without CKD

In urology we are encountering an ageing and more comorbid population, including a group of patients with chronic kidney disease (CKD). In this retrospective study, a group from the Cleveland Clinic present the extended follow-up of patients with and without...

Is TRUS and biopsy obsolete as a diagnostic test for prostate cancer: refining the perineal biopsy technique?

Whilst there has been a dramatic shift in how patients are investigated for potential prostate cancer, transrectal ultrasound (TRUS) and biopsy remains the most commonly used technique for tissue sampling. In this single centre, retrospective analysis, 634 men, over a...

Intravesical cytosine arabinoside + Mitomycin C for bladder cancer – is it beneficial?

Mitomycin C (MMC) is often used as an intravesical therapy for low / intermediate risk non-muscle invasive bladder cancer. This randomised controlled trial (RCT) was designed to assess the safety and efficacy of MMC + cytosine arabinoside (Ara-C). Ara-C was...

June Medical’s Angela Spång wins top award at Goldman Sachs 10KSB

After a rigorous application and interview process, Angela Spång, Founder & Owner of award-winning medical device company, June Medical, secured a place on the Goldman Sachs 10KSB transformative programme. She embarked on what is considered to be a condensed mini...

GentleCath™ intermittent catheters

We know that Urinary Tract Infections (UTIs) are the biggest issue for catheter users. In the United Kingdom, 14 million people suffer from continence problems1. Although hydrophilic coated catheters (2nd generation) brought benefits compared to uncoated catheters (1st generation), users...